1.
The Biology and Life-Cycle of Human Papillomaviruses
by Doorbar, John
Vaccine, 2012, Vol.30, p.F55-F70
2.
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
by Bosch, F. Xavier
Vaccine, 2008, Vol.26, p.K1-K16
3.
Cancer Inflammation by remote control
by Mantovani, Alberto
Nature, 2005-06-09, Vol.435 (7043), p.752-753
4.
Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
by Navarro-Illana, Esther
Vaccine, 2017-06-05, Vol.35 (25), p.3342-3346
5.
A risk for non-sexual transmission of human papillomavirus?
by Ryndock, Eric J
Expert review of anti-infective therapy, 2014-10, Vol.12 (10), p.1165-1170
6.
Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV)
by Poljak, Mario
Expert review of anti-infective therapy, 2017-11-02, Vol.15 (11), p.987-999
7.
Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignan...
by Theelen, Wendy, PhD
Human pathology, 2013, Vol.44 (11), p.2410-2418
8.
Wnt-11 overexpression promoting the invasion of cervical cancer cells
by Wei, Heng
Tumor biology, 2016-03-31, Vol.37 (9), p.11789-11798
9.
Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda
by Tobian, Aaron AR, Dr
The Lancet infectious diseases, 2011, Vol.11 (8), p.604-612
10.
Circumcised HIV-infected men and HPV transmission
by Giuliano, AR
The Lancet infectious diseases, 2011, Vol.11 (8), p.581-582
11.
Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
by STOREY, A
Nature (London), 1998, Vol.393 (6682), p.229-234
12.
Human papillomaviruses and the interferon response
by Beglin, Melanie
Journal of interferon & cytokine research, 2009-09, Vol.29 (9), p.629-635
13.
Immunological analyses of human papillomavirus capsids
by Giroglou, Tzenan
Vaccine, 2001, Vol.19 (13), p.1783-1793
14.
Telomerase activation by the E6 gene product of human papillomavirus type 16
by Klingelhutz, Aloysius J
Nature (London), 1996-03-07, Vol.380 (6569), p.79-82
15.
HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
by Flores, Yvonne N
Cancer causes & control, 2011-02-01, Vol.22 (2), p.261-272
16.
Interferon-tau: current applications and potential in antiviral therapy
by Chon, Thomas W
Journal of interferon & cytokine research, 2010-07, Vol.30 (7), p.477-485
17.
The role of furin in papillomavirus infection
by Day, Patricia M
Future microbiology, 2009-12-01, Vol.4 (10), p.1255-1262
18.
Immunohistochemical and HPV-related features of laryngeal adenosquamous carcinoma
by Lovato, Andrea, MD
American journal of otolaryngology, 2015, Vol.36 (3), p.442-445
19.
Accepting the Universal Truths of Cervical Human Papillomavirus Epidemiology in Pursuit of the Remaining Mysteries
by Schiffman, Mark
Sexually transmitted diseases, 2011-10-01, Vol.38 (10), p.907-908
20.
Human papillomavirus, cervical cancer prevention, and more
by Lowy, Doug
Vaccine, 2008, Vol.26, p.iii-iv
